Healius Limited logo

Healius Limited (PGZ)

Market Open
12 Jun, 20:00
XFRA XFRA
0. 20
+0.02
+9.1892%
- Market Cap
- P/E Ratio
- Div Yield
167 Volume
- Eps
0.18
Previous Close
Add Transaction
Day Range
0.2 0.2
Year Range
0.17 0.62
Want to track PGZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PGZ trading today higher at €0.2, an increase of 9.1892% from yesterday's close, completing a monthly increase of 2.5381% or €0.01. Over the past 12 months, PGZ stock lost -62.5926%.
PGZ pays dividends to its shareholders, with the most recent payment made on Sep 21, 2022. The next estimated payment will be in 21 Sep 2022 on Sep 21, 2022 for a total of €0.05554.
The last earnings report, released on Feb 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Healius Limited has completed 3 stock splits, with the recent split occurring on Nov 22, 2023.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on ASX (AUD).

PGZ Chart

Healius Limited (PGZ) FAQ

What is the stock price today?

The current price is €0.20.

On which exchange is it traded?

Healius Limited is listed on XFRA.

What is its stock symbol?

The ticker symbol is PGZ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Healius Limited ever had a stock split?

Healius Limited had 3 splits and the recent split was on Nov 22, 2023.

Healius Limited Profile

Professional Services Industry
Industrials Sector
Mr. Paul D. Anderson B.Com., C.A. CEO
XFRA Exchange
AU0000033359 ISIN
US Country
3,699 Employees
- Last Dividend
22 Aug 2018 Last Split
- IPO Date

Overview

Healius Limited is an Australian company that specializes in providing diagnostic services to both consumers and practitioners across Australia. The company operates in three main segments: Pathology, Imaging, and Others, catering to a broad range of healthcare needs. Healius Limited, initially known as Primary Health Care Limited, underwent a name change in December 2018, marking a new phase in its development. Since its incorporation in 1994, Healius Limited has established a significant presence in the Australian healthcare industry, underlined by its commitment to offering comprehensive and high-quality diagnostic and surgical services through its extensive network of facilities and brands.

Products and Services

Healius Limited offers a diverse array of healthcare services categorized under various brands, each specializing in specific areas of care:

  • Diagnostic Imaging Services - This includes a wide range of imaging tests such as MRI, CT scans, and X-rays, essential for diagnosing various medical conditions accurately.
  • Pathology Services - Provided under brand names like Laverty Pathology, Dorevitch Pathology, and others, these services encompass medical testing in laboratories for the diagnosis and management of diseases.
  • Specialized Surgical Services
    • Cataract Surgery - A procedure to remove the clouded lens of an eye and replace it with a clear, synthetic version.
    • Colonoscopy and Gastroscopy - Endoscopic examinations of the large intestine and stomach respectively, important for diagnosing gastrointestinal conditions.
    • Plastic and Cosmetic Surgery - Surgical procedures aimed at enhancing or restoring the appearance of body parts.
    • Skin Cancer Removal - Procedures for the excision of skin lesions suspected or confirmed to be cancerous.
    • IVF Egg Collection - A key step in the IVF process where eggs are collected from a woman's ovaries for fertilization in the lab.
    • Gynaecological Surgery - Surgeries related to the female reproductive system.
  • Veterinary Pathology Services - Offered under Vetpath Laboratory, Vetnostics, and other brands, these services focus on the diagnosis and treatment of animal diseases.

Contact Information

Address: 161 Castlereagh Street, Sydney, NSW, Australia, 2000
Phone: 61 2 9432 9400